T1	disease_or_phenotypic_feature 0 13	Neurotoxicity
T2	chemical 17 27	pesticides
T3	chemical 192 199	calcium
T4	chemical 204 213	uric acid
T5	disease_or_phenotypic_feature 266 284	metabolic syndrome
T6	chemical 322 326	mRNA
T7	disease_or_phenotypic_feature 347 350	PBC
T8	chemical 351 356	group
T9	chemical 381 386	group
T10	disease_or_phenotypic_feature 462 466	case
T11	chemical 468 477	molecular
T12	chemical 581 584	DNA
T13	chemical 709 714	Fatty
T14	disease_or_phenotypic_feature 709 728	Fatty Liver Disease
T15	disease_or_phenotypic_feature 787 795	Diseases
T16	chemical 867 874	antigen
T17	chemical 911 922	abiraterone
T19	disease_or_phenotypic_feature 1021 1036	prostate cancer
T20	chemical 1224 1242	anti-citrullinated
T21	chemical 1243 1250	peptide
T22	disease_or_phenotypic_feature 1301 1312	lung cancer
T23	chemical 1383 1390	Glucose
T24	chemical 1418 1426	Platinum
T25	disease_or_phenotypic_feature 1485 1500	Type 1 Diabetes
T26	disease_or_phenotypic_feature 1564 1570	cancer
T27	chemical 1608 1621	nanoparticles
T28	chemical 1625 1629	drug
T29	disease_or_phenotypic_feature 1777 1794	cold-acclimatised
T30	chemical 1843 1848	water
T31	chemical 1948 1956	estrogen
T32	disease_or_phenotypic_feature 1987 2000	breast cancer
T34	chemical 2061 2069	adjuvant
T35	disease_or_phenotypic_feature 2091 2100	mucositis
T36	missed_chemical 2119 2123	Drug
T37	missed_disease_or_phenotypic_feature 2185 2197	side effects
T38	chemical 2217 2221	drug
T39	disease_or_phenotypic_feature 2240 2246	cancer
T40	chemical 2318 2332	pharmaceutical
T41	disease_or_phenotypic_feature 2395 2404	IndSR/Aml
T42	chemical 2416 2436	amlodipine/valsartan
T43	chemical 2517 2529	vortioxetine
T44	chemical 2537 2549	vortioxetine
T45	missed_disease_or_phenotypic_feature 2584 2590	nausea
T46	disease_or_phenotypic_feature 2603 2609	common
T47	missed_disease_or_phenotypic_feature 2610 2623	adverse event
T48	disease_or_phenotypic_feature 2713 2721	glaucoma
T49	disease_or_phenotypic_feature 2760 2769	localized
T50	chemical 2770 2777	retinal
T51	disease_or_phenotypic_feature 2875 2893	depression/anxiety
T52	chemical 2898 2923	antidepressant/anxiolytic
T53	disease_or_phenotypic_feature 2967 2976	disorders
T54	disease_or_phenotypic_feature 3023 3036	pre-eclampsia
T55	disease_or_phenotypic_feature 3047 3071	gestational hypertension
T56	chemical 3144 3148	mRNA
T57	disease_or_phenotypic_feature 3211 3226	cervical cancer
T58	disease_or_phenotypic_feature 3315 3321	stroke
T59	chemical 3461 3466	group
T60	chemical 3728 3733	group
T61	chemical 3787 3793	oxygen
T62	disease_or_phenotypic_feature 3805 3812	(L-SaO2
T63	disease_or_phenotypic_feature 3941 3947	cancer
T64	chemical 4016 4019	DNA
R1	treats Arg1:T28 Arg2:T26
R3	treats Arg1:T36 Arg2:T39
R4	causes_or_contributes_to Arg1:T36 Arg2:T37
R5	causes_or_contributes_to Arg1:T43 Arg2:T45
R6	causes_or_contributes_to Arg1:T43 Arg2:T47
R7	causes_or_contributes_to Arg1:T44 Arg2:T45
R8	causes_or_contributes_to Arg1:T44 Arg2:T47
R10	treats Arg1:T38 Arg2:T39
R11	causes_or_contributes_to Arg1:T38 Arg2:T37
T65	corrected_disease_or_phenotypic_feature 2875 2885	depression
T66	corrected_disease_or_phenotypic_feature 2886 2893	anxiety
T67	corrected_chemical 2898 2912	antidepressant
T68	corrected_chemical 2913 2923	anxiolytic
R12	treats Arg1:T67 Arg2:T65	
R13	treats Arg1:T68 Arg2:T66	
T69	corrected_chemical 2057 2069	S-1 adjuvant
R2	causes_or_contributes_to Arg1:T69 Arg2:T35	
R14	causes_or_contributes_to Arg1:T2 Arg2:T1	
R9	treats Arg1:T17 Arg2:T19	
T18	corrected_chemical 1598 1621	synthetic nanoparticles
R15	treats Arg1:T18 Arg2:T26	
R16	treats Arg1:T36 Arg2:T37	
